tiprankstipranks
Trending News
More News >
Streamex (STEX)
NASDAQ:STEX
US Market

Streamex (STEX) AI Stock Analysis

Compare
418 Followers

Top Page

STEX

Streamex

(NASDAQ:STEX)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
$3.00
▼(-5.36% Downside)
The score is constrained primarily by weak financial performance (persistent losses, ongoing cash burn, and negative equity) and bearish technicals (price below key moving averages with negative MACD). Corporate events provide some offset via added liquidity and strategic actions, but valuation remains challenged due to loss-making fundamentals.
Positive Factors
Innovative Product
The PURE EP System enhances the precision of cardiac procedures, potentially improving patient outcomes and offering a competitive edge in the medical devices market.
Strategic Partnerships
Strategic partnerships can enhance technological offerings and market penetration, supporting long-term growth and competitive positioning.
Revenue Streams
Diverse revenue streams from sales, leases, and services provide a stable foundation for cash generation and business sustainability.
Negative Factors
Financial Instability
High leverage and negative equity indicate financial instability, which can limit operational flexibility and increase insolvency risk.
Cash Flow Concerns
Negative cash flow trends highlight sustainability risks, as ongoing cash burn may require external funding to maintain operations.
Declining Revenue
Declining revenue and persistent losses suggest challenges in market demand and cost management, impacting long-term profitability.

Streamex (STEX) vs. SPDR S&P 500 ETF (SPY)

Streamex Business Overview & Revenue Model

Company DescriptionBioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.
How the Company Makes MoneyBioSig Technologies generates revenue primarily through the sale and lease of its PURE EP System to hospitals and medical institutions. The company also earns money by providing ongoing support services, including maintenance and upgrades, to ensure optimal performance of its systems. Additionally, BioSig may enter into strategic partnerships and collaborations with other healthcare entities and technology providers to expand its market reach and enhance its technological offerings. Key revenue streams include direct sales, leasing agreements, and service contracts associated with the PURE EP System.

Streamex Financial Statement Overview

Summary
BioSig Technologies is facing significant financial challenges. The income statement shows persistent losses and declining revenue, while the balance sheet reflects high leverage and negative equity. Cash flow statements highlight ongoing cash burn, raising concerns about the company's ability to sustain operations without significant financial restructuring or external funding.
Income Statement
8
Very Negative
BioSig Technologies has consistently reported negative net income with a declining trend in revenue over the past years, leading to poor profitability metrics. The gross profit margin is negative, and the net profit margin has worsened substantially. This indicates significant challenges in generating revenue and managing costs effectively.
Balance Sheet
18
Very Negative
The company's balance sheet reveals high leverage with negative stockholders' equity, resulting in a negative equity ratio. The debt-to-equity ratio cannot be calculated due to negative equity, but the high level of liabilities relative to assets suggests financial instability and a potential risk of insolvency.
Cash Flow
10
Very Negative
The cash flow analysis shows negative operating and free cash flow, indicating a consistent cash burn. Although financing activities have been able to cover some of the cash outflows, the lack of positive free cash flow growth is concerning and poses a sustainability risk.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue13.00K40.00K18.00K286.00K441.00K0.00
Gross Profit-2.03M40.00K18.00K229.00K242.00K-550.00K
EBITDA-40.79M-12.42M-28.15M-26.97M-33.21M-58.59M
Net Income-39.87M-10.33M-29.04M-27.05M-31.92M-52.22M
Balance Sheet
Total Assets130.51M842.00K1.80M4.11M15.52M30.39M
Cash, Cash Equivalents and Short-Term Investments11.04M155.00K293.00K458.00K11.66M28.27M
Total Debt0.00102.00K452.00K765.00K656.00K314.00K
Total Liabilities137.34M2.26M4.68M3.71M2.95M5.11M
Stockholders Equity-6.85M-1.44M-2.91M418.00K12.35M24.48M
Cash Flow
Free Cash Flow-7.89M-4.76M-17.50M-21.87M-26.94M-26.69M
Operating Cash Flow-7.89M-4.76M-17.31M-21.70M-26.40M-26.60M
Investing Cash Flow221.00K0.00-186.00K-168.00K-542.00K-87.00K
Financing Cash Flow18.10M4.71M17.33M10.57M10.33M42.85M

Streamex Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.17
Price Trends
50DMA
3.87
Negative
100DMA
4.60
Negative
200DMA
4.41
Negative
Market Momentum
MACD
-0.23
Negative
RSI
40.88
Neutral
STOCH
34.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For STEX, the sentiment is Negative. The current price of 3.17 is below the 20-day moving average (MA) of 3.31, below the 50-day MA of 3.87, and below the 200-day MA of 4.41, indicating a bearish trend. The MACD of -0.23 indicates Negative momentum. The RSI at 40.88 is Neutral, neither overbought nor oversold. The STOCH value of 34.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for STEX.

Streamex Risk Analysis

Streamex disclosed 52 risk factors in its most recent earnings report. Streamex reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Streamex Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$210.35M9.348.45%2.70%100.41%
69
Neutral
$268.66M7.909.43%17.28%206.13%298.86%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$241.14M3.9535.45%5.39%
65
Neutral
$188.59M21.679.23%5.42%4.18%-9.53%
60
Neutral
10.239.66%17.91%630.98%234.98%
44
Neutral
$480.09M-2.29-66.67%3.34%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
STEX
Streamex
3.21
2.03
172.03%
SSSS
SuRo Capital
9.60
3.31
52.57%
EARN
Ellington Residential Mortgage
5.41
-0.25
-4.42%
TPVG
TriplePoint Venture Growth
6.65
0.06
0.91%
SAMG
SilverCrest Asset Management
15.41
-1.54
-9.09%
SWKH
SWK Holdings
17.39
4.52
35.12%

Streamex Corporate Events

Executive/Board ChangesShareholder Meetings
Streamex Shareholders Approve Proposals at 2025 Meeting
Positive
Dec 31, 2025

At its 2025 annual meeting, at which 81.21% of voting shares were represented, Streamex shareholders approved all six proposals on the agenda, reflecting overwhelming support for the company’s current governance and compensation framework. Investors re-elected Morgan Lekstrom and Karl Henry McPhie as Class I directors through the 2028 annual meeting, endorsed executive pay and set the advisory vote on compensation to occur every three years, ratified CBIZ CPAs P.C. as auditor for the 2025 fiscal year, approved an amendment to the company’s incentive plan, and backed an adjournment proposal that ultimately was not needed because a quorum was achieved, signaling broad alignment between management and shareholders on strategic and oversight priorities.

The most recent analyst rating on (STEX) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Private Placements and Financing
Streamex Secures $25 Million Convertible Debenture Financing
Positive
Dec 19, 2025

On December 17, 2025, Streamex Corp. entered into a fourth amendment to its Secured Convertible Debenture Purchase Agreement with institutional investor YA II PN, Ltd. (Yorkville), revising certain prior closing conditions without changing any material terms of the financing arrangements. On the same date, the company completed a second closing under the agreement, issuing a $25 million secured convertible debenture to Yorkville on terms broadly consistent with a prior tranche, generating approximately $24 million in gross proceeds at a 4% annual interest rate (rising to 18% upon default) and a maturity date of December 17, 2027; the instrument features a variable conversion price linked to the company’s volume‑weighted average share price, subject to anti‑dilution adjustments, a $4.00 per‑share conversion floor and a 4.99% ownership cap for the investor, as well as prepayment rights for Streamex with a 10% premium. The transaction, structured as a private offering exempt from SEC registration, provides Streamex with significant additional liquidity while introducing potential future equity dilution and preserving Yorkville’s ability to convert its debt into common stock within tightly defined pricing and ownership constraints, and follows a corporate update webinar the company hosted for investors on December 16, 2025.

The most recent analyst rating on (STEX) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Business Operations and StrategyM&A Transactions
Streamex Acquires Stake in Empress Royalty Corp.
Positive
Dec 16, 2025

On December 11, 2025, Streamex Corp. acquired a 9.9% equity interest in Empress Royalty Corp. by exchanging shares with Terra Capital Natural Resources Fund Pty Ltd. This strategic acquisition, valued at US$12,218,751, aligns with Streamex’s strategy to expand into real-world, yield-generating commodity assets, particularly in gold and silver royalties and streams. The transaction supports Streamex’s broader mission to integrate traditional commodities with regulated digital asset infrastructure, enhancing its position in the commodities and tokenization sectors.

The most recent analyst rating on (STEX) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Streamex Announces Board Changes and New Director
Neutral
Nov 19, 2025

On November 18, 2025, Streamex Corp. announced significant changes to its Board of Directors, with the resignation of three directors and the appointment of Kevin Gopaul as an independent director. Gopaul, a global financial executive with extensive experience in the ETF industry, is expected to leverage his expertise to drive Streamex’s growth and international expansion. The company also entered into employment agreements with its CEO and CFO, outlining compensation and severance terms, and filed an amendment to its Certificate of Incorporation to establish a classified Board structure.

The most recent analyst rating on (STEX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Streamex Secures $25M Financing for Gold Strategy
Positive
Nov 6, 2025

On November 4, 2025, Streamex Corp. closed the first tranche of a convertible debenture financing with Yorkville, amounting to $25,000,000. This financing is part of a larger $100,000,000 agreement and will be used to purchase physical gold bullion, aligning with Streamex’s strategy to maintain a gold-backed balance sheet. This move supports their tokenization initiatives and positions the company to benefit from the increasing demand for gold-backed financial instruments, amid a positive macro-outlook for gold. The transaction also involved several financial advisors and placement agents, and the company has committed to registering the resale of conversion shares under the Securities Act.

The most recent analyst rating on (STEX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

M&A TransactionsShareholder Meetings
Streamex Finalizes Acquisition with Stockholder Approval
Positive
Nov 4, 2025

On November 4, 2025, Streamex Corp., formerly known as BioSig Technologies, Inc., successfully concluded its special meeting of stockholders, approving the issuance of over 109 million shares of common stock and one share of Super Voting Preferred Stock as part of the acquisition of Streamex Exchange Corporation. This acquisition, initially proposed in May 2025, was finalized following stockholder approval, marking a significant step in the company’s strategic growth and positioning in the market.

The most recent analyst rating on (STEX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Business Operations and StrategyDelistings and Listing ChangesShareholder Meetings
Streamex Gains Nasdaq Approval for Continued Listing
Positive
Oct 31, 2025

On October 30, 2025, Streamex Corp. announced that it received formal approval from Nasdaq for the continued listing of its common stock on the Nasdaq Capital Market under the ticker symbol ‘STEX.’ This approval is seen as a significant milestone that will allow the company to accelerate its business plans and deliver greater value to stakeholders. Additionally, Streamex will hold a special meeting of shareholders on November 4, 2025, to reconvene the previously adjourned Acquisition Proposal for a formal vote and approval. The meeting will be held via webcast, allowing stockholders to participate, vote, and ask questions online. This development is expected to unlock substantial opportunities for GLDY stablecoin holders and further the company’s mission to modernize the gold industry.

The most recent analyst rating on (STEX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Private Placements and Financing
Streamex Secures $100M Through Convertible Debentures
Neutral
Oct 29, 2025

Streamex Corp. has amended its Secured Convertible Debenture Purchase Agreement with Yorkville, a Cayman Islands exempt limited company, to secure up to $100 million through convertible debentures. The recent amendment on October 28, 2025, mandates that $25.1 million be allocated for purchasing Allocated Vaulted Gold Bullion, with strict compliance required under a Guaranty and Security Agreement. The agreement involves a first priority security interest in the company’s assets and includes conditions such as Nasdaq approval. The first convertible debenture, valued at $25 million, will mature in 24 months with a 4% interest rate, increasing to 18% upon default.

The most recent analyst rating on (STEX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026